PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjThis ArticleThe BMJ
 
BMJ. 2007 May 19; 334(7602): 1020.
PMCID: PMC1871755
Drug Money for Patient Groups

Cancerbackup sets record straight

Joanne Rule, chief executive

Mintzes says that Cancerbackup does not list the possible side effects of trastuzumab or say where its funding comes from—this is not the case.1

Cancerbackup provides up to date and accurate information about treatment including all possible side effects, both on our website (www.cancerbackup.org.uk) and in our factsheets.

We provide a full list on our website and now in our press releases of all funders.

We are advised by an independent clinical advisory board. Pharmaceutical companies have no influence on any decision we take.

Notes

Competing interests: None declared.

References

1. Mintzes B. Should patient groups accept money from drug companies? No. BMJ 2007;334:935 (5 May.) [PMC free article] [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group